MedPath
HSA Approval

FEBRICOL TABLET

SIN11488P

FEBRICOL TABLET

FEBRICOL TABLET

April 11, 2001

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N02BE51

paracetamol, combinations excl. psycholeptics

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

PSEUDOEPHEDRINE HCl

30 mg

Pseudoephedrine

CHLORPHENIRAMINE MALEATE

2 mg

Chlorpheniramine

PARACETAMOL

500 mg

Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FEBRICOL TABLET - HSA Approval | MedPath